Cracking the Codes for Congenital Diarrhea and Enteropathies (CoDEs): A Case Report and Review
Anushka Bhowal1, Natalia Cardona1, Caroline Chua2
1Pediatrics, Nemours Children's Health, Orlando, USA.
Insights
Congenital diarrhea and enteropathies (CoDEs) can cause chronic infant diarrhea. This case highlights glucose-galactose malabsorption (GGM) diagnosis and management for infant health.
Area of Science:
- Pediatrics
- Gastroenterology
- Genetics
Background:
- Congenital diarrhea and enteropathies (CoDEs) are rare causes of chronic infant diarrhea, often posing diagnostic challenges.
- Intractable watery diarrhea in infants necessitates a thorough differential diagnosis, including malabsorptive conditions.
Abstract:
Congenital diarrhea and enteropathies (CoDEs) condition is a rare cause of chronic diarrhea in infants that can be challenging to diagnose. This article discusses key signs to recognize in considering a CoDEs diagnosis and provides an overview of the diagnostic process. We report a late preterm twin infant with intractable watery diarrhea starting shortly after birth. The infant was born from a twin pregnancy to non-consanguineous parents with an unremarkable family history. His twin brother had no complications after birth and continued to thrive. The patient initially presented with bloody stools, leading to a suspected diagnosis of necrotizing enterocolitis or cow's milk protein-induced allergic colitis. However, the emergence of profuse and watery diarrhea, failure to thrive, and hypernatremic dehydration shifted the suspicion toward malabsorptive diarrhea. An extensive workup was significant for hypernatremic metabolic acidosis and positive stool-reducing substances. Several trials of protein-hydrolysate and elemental amino acid-based formulas failed to improve symptoms. However, stool consistency improved with a trial of a carbohydrate-free, hydrolyzed protein-based formula (3232A). As a diagnostic test for specific carbohydrate malabsorption, the infant was challenged with glucose supplementation followed by fructose supplementation; his stool consistency worsened with the glucose challenge but improved with the fructose challenge. His stool pH and reducing substances were abnormal after the glucose challenge and normalized after the fructose challenge, thus indicating a clinical diagnosis of glucose-galactose malabsorption (GGM). At the time of discharge, the infant had documented weight gain and formed stools on carbohydrate-free, hydrolyzed protein-based formula (3232A) supplemented with fructose. At one-year follow-up after discharge, he continued to thrive with normal bowel movements. Outpatient genetic testing confirmed our diagnosis of GGM. GGM should be considered in infants with severe protracted, non-infectious, watery diarrhea lasting longer than two weeks. Early diagnosis and management of infants with GGM with a carbohydrate-free formula with specific carbohydrate supplementation are essential to prevent complications and ensure optimal growth and development.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:


